Development of Potent and Highly Selective Epoxyketone-Based Plasmodium Proteasome Inhibitors
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
R01GM061300
NIH HHS - United States
R01 GM061300
NIGMS NIH HHS - United States
R01 AI158612
NIAID NIH HHS - United States
R21AI146387
NIH HHS - United States
R21AI171824
NIH HHS - United States
INV-037899
Bill & Melinda Gates Foundation - United States
R21 AI146387
NIAID NIH HHS - United States
R21AI133393
NIH HHS - United States
R01AI158612
NIH HHS - United States
R21 AI171824
NIAID NIH HHS - United States
R21 AI133393
NIAID NIH HHS - United States
PubMed
36617500
PubMed Central
PMC10894724
DOI
10.1002/chem.202203958
Knihovny.cz E-zdroje
- Klíčová slova
- epoxyketone, inhibition, malaria, plasmodium, proteasome,
- MeSH
- antimalarika * farmakologie MeSH
- inhibitory proteasomu chemie MeSH
- lidé MeSH
- myši MeSH
- Plasmodium falciparum MeSH
- Plasmodium * MeSH
- proteasomový endopeptidasový komplex chemie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antimalarika * MeSH
- inhibitory proteasomu MeSH
- proteasomový endopeptidasový komplex MeSH
Here, we present remarkable epoxyketone-based proteasome inhibitors with low nanomolar in vitro potency for blood-stage Plasmodium falciparum and low cytotoxicity for human cells. Our best compound has more than 2,000-fold greater selectivity for erythrocytic-stage P. falciparum over HepG2 and H460 cells, which is largely driven by the accommodation of the parasite proteasome for a D-amino acid in the P3 position and the preference for a difluorobenzyl group in the P1 position. We isolated the proteasome from P. falciparum cell extracts and determined that the best compound is 171-fold more potent at inhibiting the β5 subunit of P. falciparum proteasome when compared to the same subunit of the human constitutive proteasome. These compounds also significantly reduce parasitemia in a P. berghei mouse infection model and prolong survival of animals by an average of 6 days. The current epoxyketone inhibitors are ideal starting compounds for orally bioavailable anti-malarial drugs.
Zobrazit více v PubMed
Malaria World Report, World Health Organization: Geneva, Switzerland, 2020.
Blasco B, Leroy Di., Fidock DA, Nat. Med 2017, 23, 917–928. PubMed PMC
Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han K-T, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin PJ, Dondorp AM, Day NP, White NJ, N. Engl. J. Med 2014, 371, 411–423. PubMed PMC
Straimer J, Gnädig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, Dacheux M, Khim N, Zhang L, Lam S, Gregory PD, Urnov FD, Mercereau-Puijalon O, Benoit-Vical F, Fairhurst RM, Ménard D, Fidock DA, Science (80-. ) 2015, 347, 428–431. PubMed PMC
Kirkman LA, Zhan W, Visone J, Dziedziech A, Singh PK, Fan H, Tong X, Bruzual I, Hara R, Kawasaki M, Imaeda T, Okamoto R, Sato K, Michino M, Alvaro EF, Guiang LF, Sanz L, Mota DJ, Govindasamy K, Wang R, Ling Y, Tumwebaze PK, Sukenick G, Shi L, Vendome J, Bhanot P, Rosenthal PJ, Aso K, Foley MA, Cooper RA, Kafsack B, Doggett JS, Nathan CF, Lin G, Proc. Natl. Acad. Sci 2018, 115, E6863–E6870. PubMed PMC
Krishnan KM, Williamson KC, Transl. Res 2018, 198, 40. PubMed PMC
Dekel E, Yaffe D, Rosenhek-Goldian I, Ben-Nissan G, Ofir-Birin Y, Morandi MI, Ziv T, Sisquella X, Pimentel MA, Nebl T, Kapp E, Ohana Daniel Y, Karam PA, Alfandari D, Rotkopf R, Malihi S, Temin TB, Mullick D, Revach OY, Rudik A, Gov NS, Azuri I, Porat Z, Bergamaschi G, Sorkin R, Wuite GJL, Avinoam O, Carvalho TG, Cohen SR, Sharon M, Regev-Rudzki N, Nat. Commun. 2021 121 2021, 12, 1–19. PubMed PMC
Manasanch EE, Orlowski RZ, Nat Rev Clin Oncol 2017, 14, 417–433. PubMed PMC
Stokes BH, Yoo E, Murithi JM, Luth MR, Afanasyev P, da Fonseca PCA, Winzeler EA, Ng CL, Bogyo M, Fidock DA, PLoS Pathog. 2019, 15, DOI 10.1371/journal.ppat.1007722. PubMed DOI PMC
Li H, Tsu C, Blackburn C, Li G, Hales P, Dick L, Bogyo M, J. Am. Chem. Soc 2014, 136, 13562–13565. PubMed PMC
Yoo E, Stokes BH, De Jong H, Vanaerschot M, Kumar TRS, Lawrence N, Njoroge M, Garcia A, Van Der Westhuyzen R, Momper JD, Ng CL, Fidock DA, Bogyo M, J. Am. Chem. Soc 2018, 140, 11424–11437. PubMed PMC
Le Chapelain C, Groll M, Angew. Chemie Int. Ed 2016, 55, 6370–6372. PubMed
LaMonte GM, Almaliti J, Bibo-Verdugo B, Keller L, Zou BY, Yang J, Antonova-Koch Y, Orjuela-Sanchez P, Boyle CA, Vigil E, Wang L, Goldgof GM, Gerwick L, O’Donoghue AJ, Winzeler EA, Gerwick WH, Ottilie S, J. Med. Chem 2017, 60, 6721–6732. PubMed PMC
Li H, O’Donoghue AJ, Van Der Linden WA, Xie SC, Yoo E, Foe IT, Tilley L, Craik CS, Da Fonseca PCA, Bogyo M, Nature 2016, 530, 233–236. PubMed PMC
Xie SC, Metcalfe RD, Mizutani H, Puhalovich T, Hanssen E, Morton CJ, Du Y, Dogovski C, Huang SC, Ciavarri J, Hales P, Griffin RJ, Cohen LH, Chuang BC, Wittlin S, Deni I, Yeo T, Ward KE, Barry DC, Liu B, Gillett DL, Crespo-Fernandez BF, Ottilie S, Mittal N, Churchyard A, Ferguson D, Aguiar ACC, Guido RVC, Baum J, Hanson KK, Winzeler EA, Gamo FJ, Fidock DA, Baud D, Parker MW, Brand S, Dick LR, Griffin MDW, Gould AE, Tilley L, Proc. Natl. Acad. Sci. U. S. A 2021, 118, DOI 10.1073/PNAS.2107213118. PubMed DOI PMC
Zhan W, Zhang H, Ginn J, Leung A, Liu YJ, Michino M, Toita A, Okamoto R, Wong TT, Imaeda T, Hara R, Yukawa T, Chelebieva S, Tumwebaze PK, Lafuente-Monasterio MJ, Martinez-Martinez MS, Vendome J, Beuming T, Sato K, Aso K, Rosenthal PJ, Cooper RA, Meinke PT, Nathan CF, Kirkman LA, Lin G, Angew. Chemie - Int. Ed 2021, 60, 9279–9283. PubMed PMC
Zhang H, Ginn J, Zhan W, Liu YJ, Leung A, Toita A, Okamoto R, Wong T-T, Imaeda T, Hara R, Yukawa T, Michino M, Vendome J, Beuming T, Sato K, Aso K, Meinke PT, Nathan CF, Kirkman LA, Lin G, J. Med. Chem 2022, DOI 10.1021/ACS.JMEDCHEM.2C00611. PubMed DOI PMC
Lin G, Chidawanyika T, Tsu C, Warrier T, Vaubourgeix J, Blackburn C, Gigstad K, Sintchak M, Dick L, Nathan C, J. Am. Chem. Soc 2013, 135, 9968–9971. PubMed PMC
De Bruin G, Huber EM, Xin BT, Van Rooden EJ, Al-Ayed K, Kim KB, Kisselev AF, Driessen C, Van Der Stelt M, Van Der Marel GA, Groll M, Overkleeft HS, J. Med. Chem 2014, 57, 6197–6209. PubMed
Trager W, Jensen JB, Science (80-. ) 1976, 193, 673–675. PubMed
Swann J, Corey V, Scherer CA, Kato N, Comer E, Maetani M, Antonova-Koch Y, Reimer C, Gagaring K, Ibanez M, Plouffe D, Zeeman AM, Kocken CHM, McNamara CW, Schreiber SL, Campo B, Winzeler EA, Meister S, ACS Infect. Dis 2016, 2, 281–293. PubMed PMC
Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M, Antimicrob. Agents Chemother 2004, 48, 1803–1806. PubMed PMC
Xie SC, Metcalfe RD, Hanssen E, Yang T, Gillett DL, Leis AP, Morton CJ, Kuiper MJ, Parker MW, Spillman NJ, Wong W, Tsu C, Dick LR, Griffin MDW, Tilley L, Nat. Microbiol. 2019 411 2019, 4, 1990–2000. PubMed
Scholz C, Knorr S, Hamacher K, Schmidt B, J. Chem. Inf. Model 2015, 55, 398–406. PubMed
Evaluating Antimalarial Proteasome Inhibitors for Efficacy in Babesia Blood Stage Cultures